Sanara MedTech Inc. (SMTI) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts SMTI Hot Sheet
Join SI Premium – FREE
Sanara MedTech Inc. (NASDAQ: SMTI) reported Q2 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $28.14 million versus the consensus estimate of $28.95 million.
For earnings history and earnings-related data on Sanara MedTech Inc. (SMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Offerpad to move stock listing from NYSE to Nasdaq
- Freedom Broker Downgrades Flexsteel (FLXS) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
